A股異動 | 中集車輛漲近6% 北美冷藏半掛車銷量同比大增178.5%
格隆匯12月10日丨中集車輛(301039.SZ)現漲5.95%,報14.42元,總市值291億元。12月9日,中集車輛在投資者互動平台表示,2021年前三季度,公司於北美市場的半掛車業務收入同比增長8.6%。逐漸化解全球化逆風對本公司帶來的影響,受益於北美市場本地化產線的優化以及迅速激增的市場需求,北美冷藏半掛車銷量同比大幅增長178.5%。另外,公司積極研發及推廣新能源、智能化、數字化與輕量化的綠色產品。目前,公司的專用車上裝業務與新能源汽車主機廠形成業務合作。中國的主機廠正在新能源底盤研發方面前行,作為專用車上裝生產企業,本公司積極與主機廠聯合發展推進新能源在專用車整車上的研發與應用。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.